National trends in osteoporosis visits and osteoporosis treatment, 1988-2003.
about
Denosumab for the treatment and prevention of postmenopausal osteoporosisSystematic review and meta-analysis of the performance of clinical risk assessment instruments for screening for osteoporosis or low bone densityLong-term effect of the Women's Health Initiative study on antiosteoporosis medication prescribingA randomized study of the effect of 5-year and lifetime hip fracture risk information on physician recommendations for management of low bone density.Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151 patients.Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR dental PBRNPerformance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic reviewIf you don't take it - it can't work: the consequences of not being treated or nonadherence to osteoporosis therapy.Genetic investigation of bisphosphonate-related osteonecrosis of jaw (BRONJ) via whole exome sequencing and bioinformatics.Trends in incidence of subtrochanteric fragility fractures and bisphosphonate use among the US elderly, 1996-2007.Effectiveness of bisphosphonates on nonvertebral and hip fractures in the first year of therapy: the risedronate and alendronate (REAL) cohort studyIncidence and mortality of hip fractures in the United StatesAssociation of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.Secular trends in the incidence of primary hyperparathyroidism over five decades (1965-2010)Comparative gastrointestinal safety of weekly oral bisphosphonates.Prevalence and trends in low femur bone density among older US adults: NHANES 2005-2006 compared with NHANES III.Update in women's health 2006-2007.Osteoporosis: how should it be treated?Calcium intake and disease prevention.Longitudinal trends in use of bone mass measurement among older americans, 1999-2005.Fracture risk in type 2 diabetes: update of a population-based study.BFH-OST, a new predictive screening tool for identifying osteoporosis in postmenopausal Han Chinese women.Delayed healing of lower limb fractures with bisphosphonate therapy.Decayed, Missing, and Filled Teeth Index and Periodontal Health in Osteoporotic Patients Affected by BRONJ: An Observational Study.Increase in prophylaxis of glucocorticoid-induced osteoporosis by pharmacist feedback: a randomised controlled trial.Trends in fracture incidence: a population-based study over 20 years.Changes in frailty-related characteristics of the hip fracture population and their implications for healthcare services: evidence from Quebec, Canada.Declining Rates of Hip Fracture in End-stage Renal Disease: Analysis from the 2003-2011 Nationwide Inpatient Sample.Changes in femur neck bone density in US adults between 1988-1994 and 2005-2008: demographic patterns and possible determinants.Surgical trauma and low-dose methylprednisolone modulate the severity of the acute-phase response induced by zoledronic acid infusion.Patterns of treatment among a cohort of older low-income adults starting new medications for osteoporosis.Secular decreases in fracture rates 1986-2006 for Manitoba, Canada: a population-based analysis.Physician differences in managing postmenopausal osteoporosis: results from the POSSIBLE US™ treatment registry study.Comparison of the effect of denosumab and alendronate on BMD and biochemical markers of bone turnover in postmenopausal women with low bone mass: a randomized, blinded, phase 3 trial.Interview with Dr. Dee Edington, PhD.Denosumab - a new medication in the treatment of postmenopausal osteoporosis.Protective Effects of 2,3,5,4'-Tetrahydroxystilbene-2--β-d-glucoside on Ovariectomy Induced Osteoporosis Mouse Model
P2860
Q24201859-10BAC1D7-FDA0-475C-8846-255A8609FE4EQ27026680-15E7EBB0-486D-4C7B-9891-1F3E885F9EE9Q33874953-6E409F7E-96FD-4576-B815-D17F98694D06Q33902507-6D6582B2-7ADE-4078-B557-066C650556C7Q34035088-94956008-6662-4B8D-90BA-53BF7650EDBBQ34164223-C8898817-5C27-4153-AE67-CA9804424188Q35012083-0EF0499D-3E16-4C70-9A94-01D18B3D7BADQ35050249-14B2C419-85A1-4C23-9A0D-D3E36601D538Q35112085-EE7EB27F-D2ED-4A0F-9049-D249C428EEA4Q35229889-72C7105A-1BC2-4C9F-BB16-B7CDCEC4D3A6Q35230210-26B07CF4-6CFF-498E-94D3-1343B833F495Q35541830-DCC2FA64-E790-498D-91EE-C35AFDB15D9CQ35556799-37B88CEA-FF38-4963-A264-408F8D30F162Q35654613-79F0F474-581D-4E9B-8FA5-7A32EA5D78E7Q35670045-8F394EFB-3C24-46EF-9EF4-ED2372CEC576Q35853932-313F5F2B-EB57-4983-90E5-CFB5D470B6BFQ36325450-DAB6E172-4E67-43C8-91D9-E56534211432Q36583646-79C1D7B6-3AA9-4459-8D2C-826023AC1B63Q36658936-77A33608-0574-49CC-AF32-4DA375407DC4Q36813581-05DC351A-2966-4A34-B988-56AE192A8808Q36952446-A9BC05DE-EDB5-4791-885E-0B6CBC839C73Q37158394-BE02CEE6-9C02-4CD2-9BBC-BC098D0D6743Q37395277-D081A5C7-6C44-44A7-AB19-67CD1DD920AEQ37422398-C435F3DB-1A5B-42F8-9287-8A73BFA757D1Q37469282-CE85901D-4AB1-49B3-A87B-03069AF960B4Q37593831-3FBD86E1-ECDF-4F99-831D-77C82332C461Q38112571-01F2F479-B61D-4AFF-AEF4-F635C512597CQ38714295-D4E84FFC-CD9C-4A5B-95EC-3FE36D14A97CQ39744556-3050170F-42A0-4632-8018-3421CB8F701CQ41115341-8A4D1EB3-A42C-45CC-931D-12BD65716DC8Q43816732-3C8D5BB6-E5E3-446B-857E-BC5FB186AE08Q43960029-AB181DA8-17BF-4DD9-B88C-931CA869E59EQ45345590-E769E19B-D47C-46BE-B1DC-350AEDF381D1Q46393065-5B7819F3-5748-40FE-B66D-5FFC01046288Q48405183-6DDC4110-068C-4B44-80E7-6E7146A3428FQ52673042-738948B2-9B54-46B9-AA87-BC3018CC09A1Q58697346-13626F73-834E-4823-B628-F8DC1B9AD7F4
P2860
National trends in osteoporosis visits and osteoporosis treatment, 1988-2003.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
National trends in osteoporosis visits and osteoporosis treatment, 1988-2003.
@en
National trends in osteoporosis visits and osteoporosis treatment, 1988-2003.
@nl
type
label
National trends in osteoporosis visits and osteoporosis treatment, 1988-2003.
@en
National trends in osteoporosis visits and osteoporosis treatment, 1988-2003.
@nl
prefLabel
National trends in osteoporosis visits and osteoporosis treatment, 1988-2003.
@en
National trends in osteoporosis visits and osteoporosis treatment, 1988-2003.
@nl
P2093
P1476
National trends in osteoporosis visits and osteoporosis treatment, 1988-2003.
@en
P2093
Adam L Hersh
Randall S Stafford
Rebecca L Drieling
P304
P356
10.1001/ARCHINTE.164.14.1525
P407
P577
2004-07-01T00:00:00Z